Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

Consumer Defensive Tobacco
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives

GlobeNewswire March 3, 2023

22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference

GlobeNewswire March 2, 2023

22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023

GlobeNewswire February 23, 2023

22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand's Reduced-Nicotine Content Tobacco Law

GlobeNewswire February 22, 2023

Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That "Helps You Smoke Less"  

GlobeNewswire February 7, 2023

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position

GlobeNewswire January 24, 2023

22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs

GlobeNewswire January 23, 2023

Grabar Law Office Investigates Claims on Behalf of Shareholders of 22nd Century Group, Inc. (XXII) as Securities Fraud Class Action Survives Motion to Dismiss

Newsfile January 19, 2023

22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown

Newsfile January 18, 2023

FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

Newsfile January 17, 2023

Grabar Law Office Investigates Claims on Behalf of Shareholders of 22nd Century Group, Inc. (XXII) As Securities Fraud Class Action Survives Motion to Dismiss

Newsfile January 10, 2023

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews John Miller President, 22nd Century Group Inc.

Accesswire December 16, 2022

22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law

Newsfile December 13, 2022

22nd Century Group Provides Update on Grass Valley Facility

Newsfile December 8, 2022

22nd Century Group Provides Update on Incident at Grass Valley Facility

Newsfile November 21, 2022

22nd Century Group's GVB Biopharma Opens New Central Distribution Facility in The Netherlands

GlobeNewswire November 16, 2022

22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas

GlobeNewswire November 15, 2022

22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences

GlobeNewswire November 14, 2022

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022

GlobeNewswire November 8, 2022

New Study Again Shows 22nd Century's Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation

GlobeNewswire November 7, 2022